Delaying the Onset of Type 1 Diabetes with Teplizumab: A Narrative Review of Autoantibody Screening and Who Would Actually Be Treated. (2022). Journal of Clinical Diabetes and Obesity, 2(1), 7-12. https://doi.org/10.5281/zenodo.22238844